Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: A statistical modeling perspective

Seminars in Nephrology

Volumn 25, Issue 1, 2005, Pages 25-31

  Short, Robert A ^a   Tuttle, Katherine R ^a  

^a Heart Institute of Spokane   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; KIDNEY DISEASE; LIFESTYLE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; OBESITY; OUTCOMES RESEARCH; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL;

EID: 12244282607     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.09.005     Document Type: Article

References (80)

1. D.S. Freedman, D.F. Williamson, E.W. Gunter Relation of serum uric acid to mortality and ischemic heart disease The NHANES I epidemiologic follow-up study Am J Epidemiol 141 1995 637 644
2. W.B. Kannel Metabolic risk factors for coronary heart disease in women Perspective from the Framingham Study Am Heart J 114 1987 413 418
3. W. Levine, A.R. Dyer, R.B. Shekelle Serum uric acid and 11.5-year mortality of middle-aged women Findings of the Chicago Heart Association Detection Project in Industry J Clin Epidemiol 42 1989 257 267
4. A. Reunanen, H. Takkunen, P. Knekt Hyperuricemia as a risk factor for cardiovascular mortality Acta Med Scand 668 1982 S49 S59
5. R.F. Gillum, M.E. Mussolino, J.H. Madans Fish consumption and hypertension incidence in African Americans and whites The NHANES I epidemiologic follow-up study J Natl Med Assoc 93 2001 124 128
6. S. Paeratakul, J.C. Lovejoy, D.H. Ryan The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults Int J Obes Relat Metab Disord 26 2002 1205 1210
7. R.F. Gillum, M.E. Mussolino, J.H. Madans Coronary heart disease incidence and survival in African-American women and men. The NHANES I epidemiologic follow-up study Ann Intern Med 127 1997 111 118
8. M.H. Alderman, H. Cohen, S. Madhavan Serum uric acid and cardiovascular events in successfully treated hypertensive patients Hypertension 34 1999 144 150
9. B. Stengel, M.E. Tarver-Carr, N.R. Powe Lifestyle factors, obesity and the risk of chronic kidney disease Epidemiology 14 2003 479 487
10. M.J. Klag, P.K. Whelton, B.L. Randall End-stage renal disease in African-American and white men. 16-year MRFIT findings JAMA 277 1997 1293 1298
11. J. Fang, M.H. Alderman Serum uric acid and cardiovascular mortality The NHANES I epidemiologic follow-up study, 1971-1992 JAMA 283 2000 2404 2410
12. R.D. Abbott, F.N. Brand, W.B. Kannel Gout and coronary heart disease The Framingham study J Clin Epidemiol 41 1988 237 242
13. C. Iribarren, D.S. Sharp, J.D. Curb High uric acid A metabolic marker of coronary heart disease among alcohol abstainers? J Clin Epidemiol 49 1996 673 678
14. V.F. Franse, M. Pahor, M. Di Bari Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) J Hypertens 18 2000 1149 1154
15. C. Bengtsson, L. Lapidus, C. Stendahl Hyperuricaemia and risk of cardiovascular disease and overall death Acta Med Scand 224 1988 549 555
16. N. Nakanishi, K. Tatara, K. Nakamura Risk factors for the incidence of hyperuricaemia A 6-year longitudinal study of middle-aged Japanese men Int J Epidemiol 28 1999 888 893
17. H.K. Choi, K. Atkinson, E.W. Karlson Purine-rich foods, dairy and protein intake, and the risk of gout in men N Engl J Med 350 2004 1093 1103
18. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel, III). National Cholesterol Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Circulation 106 2002 3143 3421
19. K.G. Alberti, P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
20. R.A. DeFronzo, E. Ferrannini Insulin resistance. A multifaceted syndrome responsible for NIDDM obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194
21. H.M. Lakka, D.E. Laaksonen, T.A. Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
22. N. Sattar, A. Gaw, O. Scherbakova Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419
23. J. Chen, P. Muntner, L. Hamm The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 2004 167 174
24. S.G. Wannamethee, A.G. Shaper, P.H. Whincup Serum urate and the risk of major coronary heart disease events Heart 78 1997 147 153
25. S.G. Wannamethee Is serum uric acid a risk factor for coronary heart disease J Hum Hypertens 13 1999 153 156
26. I. Zavaroni, S. Mazza, M. Fantuzzi Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia J Intern Med 234 1993 25 30
27. J. Staessen Members of the European Working Party on High Blood Pressure in the Elderly The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly Trial Am J Med 90 1991 50S 54S
28. V.W. Persky, A.R. Dyer, E. Idris-Soven Uric acid A risk factor for coronary heart disease? Circulation 59 1979 969 977
29. W. Rathmann, H. Hauner, K. Dannehl Association of elevated serum uric acid with coronary heart disease in diabetes mellitus Diabetes Metab 9 1993 159 166
30. K. Masuo, H. Kawaguchi, H. Mikami Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation Hypertension 42 2003 474 480
31. K.R. Tuttle, R.A. Short, R.J. Johnson Sex differences in uric acid and risk factors for coronary artery disease Am J Cardiol 87 2001 1411 1414
32. R.A. Short, R.J. Johnson, K.R. Tuttle Uric acid predicts cardiovascular disease in the absence of hypertension and independent of diuretic therapy, renal function, and microalbuminuria J Am Soc Nephrol 14 2003 676A
33. J. Tuomilehto, P. Zimmet, E. Wolf Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji Am J Epidemiol 127 1988 321 336
34. S. Weitzman, M. Maislos, B. Bodner-Fishman Association of diabetic retinopathy, ischemic heart disease, and albuminuria with diabetic treatment in type 2 diabetic patients Acta Diabetol 34 1997 275 279
35. F. Leyva, S. Anker, J.W. Swan Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure Eur Heart J 18 1997 858 865
36. The Hypertension Detection and Follow-up Program Cooperative Research Group Mortality findings for stepped-care and referred-care participants in the Hypertension Detection and Follow-up Program, stratified by other risk factors Prev Med 14 1985 312 335
37. R.J. Johnson, D.H. Kang, D. Feig Is there a pathogenic role for uric acid in hypertension, cardiovascular and renal disease? Hypertension 41 2003 1183 1190
38. F.N. Brand, D.L. McGee, W.B. Kannel Hyperuricemia as a risk factor of coronary heart disease The Framingham study Am J Epidemiol 121 1985 11 18
39. J.G. Puig, L.M. Ruilope Uric acid as a cardiovascular risk factor in arterial hypertension J Hypertens 17 1999 869 872
40. J.V. Selby, G.D. Friedman, C.P. Quesenberry Precursors of essential hypertension Pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries Am J Epidemiol 131 1990 1017 1027
41. F. Jossa, E. Farinaro, S. Panico Serum uric acid and hypertension The Olivetti heart study J Hum Hypertens 8 1994 677 681
42. R.J. Torres, M.A. Martinez, T. Sancho Serum uric acid levels and microalbuminuria in mild hypertensive patients Adv Exp Med Biol 486 2000 135 137
43. D.I. Feig, R.J. Johnson Hyperuricemia in childhood primary hypertension Hypertension 42 2003 247 252
44. C.J. Bulpitt, D.G. Beevers, A. Butlier The survival of treated hypertensive patients and their causes of death A report from the DHSS Hypertensive Care Computing Project (DHCCP) J Hypertens 4 1986 93 99
45. B.F. Culleton, M.G. Larson, W.B. Kannel Serum uric acid and risk for cardiovascular disease and death The Framingham Heart Study Ann Intern Med 131 1999 7 13
46. B.F. Culleton Uric acid and cardiovascular disease A renal-cardiac relationship? Curr Opin Nephrol Hypertens 10 2001 371 375
47. A.D. Liese, H.W. Hense, H. Löwel Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg Cohort Epidemiology 10 1999 391 397
48. E. Casiglia, P. Spolaore, G. Ginocchio Predictors of mortality in very old subjects aged 80 years or over Eur J Epidemiol 9 1993 577 586
49. J.G. Wang, J.A. Staessen, R.H. Fagard Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension Hypertension 37 2001 1069 1074
50. C. Bickel, H.J. Rupprecht, S. Blankenberg Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease Am J Cardiol 89 2002 12 17
51. R.J. Goldberg, C.M. Burchfiel, R. Benfante Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men Arch Intern Med 155 1995 686 694
52. P. Verdecchia, G. Schillaci, G. Reboldi Relation between serum uric acid and risk of cardiovascular disease in essential hypertension The PIUMA Study Hypertension 36 2000 1072 1078
53. The Coronary Drug Project Research Group Serum uric acid Its association with other risk factors and with mortality in coronary heart disease J Chron Dis 29 1976 557 569
54. P.W. De Leeuw, L. Thijs, W.H. Birkenhäger Prognostic significance of renal function in elderly patients with isolated systolic hypertension Results from the Syst-Eur Trial J Am Soc Nephrol 13 2002 2213 2222
55. J.T. Moriarity, A.R. Folsom, C. Iribarren Serum uric acid and risk of coronary heart disease Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 10 2003 136 143
56. R.J. Johnson, K.R. Tuttle Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease Hypertension 35 2000 E10
57. A. Kagan, T. Gordon, G.G. Rhoads Some factors related to coronary heart disease incidence in Honolulu Japanese Men The Honolulu Heart Study Int J Epidemiol 4 1975 271 279
58. H.J. Ward Uric acid as an independent risk factor in the treatment of hypertension Lancet 352 1998 670 671
59. F.J. Nieto, C. Iribarren, M.D. Gross Uric acid and serum antioxidant capacity A reaction to atherosclerosis? Atherosclerosis 148 2000 131 139
60. F. Leyva, S.D. Anker, I.F. Godsland Uric acid in chronic heart failure A marker of chronic inflammation Eur Heart J 19 1998 1814 1822
61. S.D. Anker, W. Doehner, M. Rauchhaus Uric acid and survival in chronic heart failure Validation and application in metabolic, functional, and hemodynamic staging Circulation 107 2003 1991 1997
62. F. Leyva, T.P. Chua, S.D. Anker Uric acid in chronic heart failure A measure of the anaerobic threshold Metabolism 47 1998 1156 1159
63. J. Segura, C. Campo, L.M. Ruilope How relevant and frequent is the presence of mild renal insufficiency in essential hypertension? J Clin Hypertens 4 2002 332 336
64. G. Leoncini, F. Viazzi, D. Parodi Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension Hypertension 42 2003 14 18
65. K. Iseki, S. Oshiro, M. Tozawa Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects Hypertens Res 24 2001 691 697
66. M. Tomita, S. Mizuno, H. Yamanaka Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers J Epidemiol 10 2000 403 409
67. R. Bigazzi, S. Bianchi, D. Baldari Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension J Hypertens 16 1998 1325 1333
68. L.M. Ruilope, J. Garcia-Puig Hyperuricemia and renal function Curr Hypertens Rep 3 2001 197 202
69. H. Geiger, U. Bahner, A. Heidland Does cadmium contribute to the development of renal parenchymal hypertension Int J Artif Organs 12 1989 733 737
70. H. Geiger, U. Bahner, S. Anderes Cadmium and renal hypertension J Hum Hypertens 3 1989 23 27
71. E. Miranda-Carus, F.A. Mateos, A.G. Sanz Purine metabolism in patients with gout The role of lead Nephron 75 1997 327 335
72. U. Gerhardt, H.M. Grosse, H. Hohage Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients Clin Transplant 13 1999 375 379
73. I. Ohno, T. Hosoya, H. Gomi Serum uric acid and renal prognosis in patients with IgA nephropathy Nephron 87 2001 333 339
74. J. Syrjanen, J. Mustonen, A. Pasternack Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy Nephrol Dial Transplant 15 2000 34 42
75. L.G. Hunsicker, S. Adler, A. Caggiula Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 1997 1908 1919
76. L.R. James, S.A. Mulaik, J.M. Brett Causal Analysis Assumptions, Models, and Data 1982 Sage Publications, Inc Beverly Hills, CA
77. J.C. Joehlin Latent Variable Models An Introduction to Factor, Path, and Structural Analysis 1987 Lawrence Erlbaum Associates Hillsdale, NJ
78. L.A. Hayduk Structural Equation Modeling with LISREL Essentials and Advances 1987 The Johns Hopkins University Press Baltimore
79. A. Breckenridge Hypertension and hyperuricaemia Lancet 1 1966 15 18
80. R.J. Johnson, S.D. Kivlighn, Y.G. Kim Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease Am J Kidney Dis 33 1999 225 234